Opportunity
DIBBS #SPE2DP-26-T-3234
DLA Solicitation for Moxifloxacin Hydrochloride Tablets (70 Bottles, Fort Bragg Delivery)
Posted
May 05, 2026
Respond By
May 11, 2026
Identifier
SPE2DP-26-T-3234
NAICS
325412, 424210
This opportunity involves the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain seeking Moxifloxacin Hydrochloride Tablets for delivery to a military installation. - Government Buyer: - Defense Logistics Agency (DLA), Troop Support Medical Supply Chain Pharm FSA, Philadelphia, PA - OEMs (Original Equipment Manufacturers): - TEVA PHARMACEUTICALS USA, INC. - DR REDDY'S LABORATORIES, INC. - RISING PHARMA HOLDINGS, INC. - Vendors/Manufacturers: - TEVA PHARMACEUTICALS USA, INC. (NDC00093-7387-56) - DR REDDY'S LABORATORIES, INC. (NDC55111-0112-30) - RISING PHARMA HOLDINGS, INC. (NDC57237-0156-30) - Products/Quantities: - Moxifloxacin Hydrochloride Tablets, 400 mg, 30 tablets per bottle - National Stock Number (NSN): 6505-01-503-4772 - Total quantity: 70 bottles - Notable Requirements: - Strict packaging and hazardous material labeling per MIL-STD-2073-1E and Medical Marking Standard No. 1A - Shelf life requirement: 36 months, non-extendable - Compliance with domestic sourcing laws and cybersecurity assessments - Delivery required within 20 days, FOB destination to Fort Bragg, NC
Description
MOXIFLOXACIN HYDROC (QTY: 70, NSN: 6505-01-503-4772, Purchase Request: 7016613594) Approved Sources: - CAGE: 3V8D7, Part No: NDC00093-7387-56, Company: TEVA PHARMACEUTICALS USA, INC. - CAGE: 4E8M8, Part No: NDC55111-0112-30, Company: DR REDDY'S LABORATORIES, INC. - CAGE: 8FG82, Part No: NDC57237-0156-30, Company: RISING PHARMA HOLDINGS, INC.